Found: 17
Select item for more details and to access through your institution.
Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Expression of neurotensin receptor-1 (NTS<sub>1</sub>) in primary breast tumors, cellular distribution, and association with clinical and biological factors.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 403, doi. 10.1007/s10549-021-06402-5
- By:
- Publication type:
- Article
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 463, doi. 10.1007/s10549-021-06400-7
- By:
- Publication type:
- Article
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 435, doi. 10.1007/s10549-021-06399-x
- By:
- Publication type:
- Article
Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 373, doi. 10.1007/s10549-021-06398-y
- By:
- Publication type:
- Article
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I–III unilateral breast cancer in the USA, 1998–2016.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 503, doi. 10.1007/s10549-021-06397-z
- By:
- Publication type:
- Article
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 425, doi. 10.1007/s10549-021-06396-0
- By:
- Publication type:
- Article
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 517, doi. 10.1007/s10549-021-06394-2
- By:
- Publication type:
- Article
Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 491, doi. 10.1007/s10549-021-06393-3
- By:
- Publication type:
- Article
Sleep medication use and risk of fractures in breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 541, doi. 10.1007/s10549-021-06392-4
- By:
- Publication type:
- Article
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 477, doi. 10.1007/s10549-021-06391-5
- By:
- Publication type:
- Article
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 357, doi. 10.1007/s10549-021-06387-1
- By:
- Publication type:
- Article
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 451, doi. 10.1007/s10549-021-06386-2
- By:
- Publication type:
- Article
Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 531, doi. 10.1007/s10549-021-06381-7
- By:
- Publication type:
- Article
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 415, doi. 10.1007/s10549-021-06375-5
- By:
- Publication type:
- Article
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 389, doi. 10.1007/s10549-021-06339-9
- By:
- Publication type:
- Article
Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 3, p. 549, doi. 10.1007/s10549-021-06311-7
- By:
- Publication type:
- Article